Regaining virological suppression in a woman living with a six‐class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests-Reference-Cited by-同舟云学术

Regaining virological suppression in a woman living with a six‐class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests

Published:2024-07-26 Issue:8 Volume:96 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Monti Bianca¹²,Soria Alessandro²^ORCID,Saladini Francesco³,Lapadula Giuseppe¹²,Squillace Nicola²,Giammarino Federica³⁴,Paletti Chiara³,Bartolini Niccolò³,Spagnuolo Vincenzo⁵,Castagna Antonella⁵,Zazzi Maurizio³,Bonfanti Paolo¹²

Affiliation:

1. School of Medicine University of Milano‐Bicocca Monza Italy

2. Clinic of Infectious Diseases Fondazione IRCCS San Gerardo dei Tintori Monza Italy

3. Department of Medical Biotechnologies University of Siena Siena Italy

4. Department of Medicine Huddinge, Division of Infectious Diseases Karolinska Institutet Stockholm Sweden

5. Clinic of Infectious Diseases, San Raffaele Scientific Institute Vita‐Salute University Milan Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29832

Reference11 articles.

1. HIV-1 drug resistance and resistance testing

2. Ending the HIV/AIDS Pandemic1

3. HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts

4. Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

5. Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors